Yes, binge eating disorder (BED) is a formally recognized eating disorder. It was added to the Diagnostic and Statistical Manual of Mental Disorders in 2013, and it is the most common eating disorder in the United States, affecting an estimated 2.8% of Americans at some point in their lives. That makes it roughly three times more prevalent than bulimia nervosa and nearly five times more common than anorexia nervosa.
What Makes It a Clinical Disorder
BED is characterized by recurrent episodes of eating an objectively large amount of food within a short window, typically around two hours, accompanied by a feeling of losing control. To meet the diagnostic threshold, these episodes need to happen at least once a week for three months and cause significant distress. The key distinction from bulimia is that people with BED do not follow binges with purging, excessive exercise, or other compensatory behaviors.
The International Classification of Diseases (ICD-11), used by health systems worldwide, defines BED in essentially the same way: recurrent episodes of excessive food consumption with loss of control and associated distress, without regular compensatory behaviors.
Overeating vs. Binge Eating Disorder
Nearly everyone overeats occasionally. Going back for thirds at a holiday dinner or finishing an entire pizza on a Friday night doesn’t mean you have BED. The difference comes down to frequency, volume, and most importantly, the feeling of being unable to stop. People experiencing a binge episode often eat very rapidly, eat when they aren’t hungry, eat until they’re physically uncomfortable, and eat alone because they feel ashamed. Afterward, they typically feel disgusted, guilty, or deeply upset about what happened.
That emotional pattern is central to the diagnosis. Occasional overindulgence doesn’t carry that same cycle of distress and loss of control. If eating regularly feels like something that happens to you rather than something you choose, that’s closer to what BED looks like.
What Happens in the Brain During a Binge
BED has a neurological basis, not just a behavioral one. Research from Brookhaven National Laboratory found that when people with BED are exposed to the sight and smell of food, their brains release significantly more dopamine in reward-related areas compared to people without the disorder. People with the most severe symptoms showed the highest dopamine spikes.
The brain region most affected, the caudate, is involved in reinforcing actions that lead to reward. It’s the same region that lights up in people with substance use disorders. In practical terms, this means the brain of someone with BED is being primed to seek food as a reward in a way that goes beyond normal hunger or appetite. This doesn’t make binge eating a choice or a failure of willpower. It’s a pattern driven by brain chemistry.
Physical Health Risks
Left untreated, BED increases the risk of several serious health conditions. These include high blood pressure, high cholesterol, heart disease, type 2 diabetes, and gallbladder disease. Because BED often leads to weight gain over time, many of these risks compound with one another. But it’s worth noting that BED can affect people at any weight, and the disorder itself, not just the weight it may cause, contributes to metabolic disruption.
How BED Is Treated
The first-line treatment for BED is cognitive behavioral therapy (CBT), which has been the standard approach since the late 1990s. A head-to-head comparison of group CBT and interpersonal therapy (IPT) in 162 patients found similar recovery rates after treatment: 79% for CBT and 73% for IPT. At the one-year follow-up, both groups held steady, with 59% and 62% still in recovery, respectively.
Longer-term data is encouraging. A follow-up study four years after treatment ended found that over 64% of patients maintained full recovery from binge eating, and 80% showed clinically significant improvement. One interesting nuance: IPT patients maintained more stable abstinence over time, while CBT patients showed a slightly higher tendency to relapse in the long run. Both therapies, though, produced durable results for the majority of people.
On the medication side, the FDA has approved lisdexamfetamine for moderate to severe BED in adults. It was originally developed for ADHD and works by affecting dopamine and norepinephrine signaling in the brain. Common side effects include dry mouth, trouble sleeping, decreased appetite, increased heart rate, constipation, and feeling jittery. Medication is generally used alongside therapy rather than as a standalone treatment.
Why Recognition Matters
For decades, binge eating was dismissed as a lack of discipline or lumped in with general overeating. Its inclusion as a distinct diagnosis changed how insurance covers treatment, how clinicians screen for it, and how people who struggle with it understand their own experience. Knowing that BED is a recognized disorder with neurological underpinnings and effective treatments can be the difference between years of shame and actually getting help that works.